HOME > EXPOSÉ

Avexxin AS-www.avexxin.com

Avexxin AS introduces a new therapeutic approach for inflammatory diseases, based on a novel intervention point within the proinflammatory process. The approach will be initially target on the psoriasis disease, that currently highly miss any efficient and save treatment. Avexxin’s therapeutics are anticipated to be more specific and to be interfering with fewer general biological process, therefore suggest less toxicity and less adverse effects in the patient. In addition to this, production costs are significant lower compared to many current therapeutics.

Santaris Pharma A/S – www.santaris.com

Santaris Pharma is a science-based, product-driven, biopharmaceutical company focused on oncology. The company mission is to discover, develop and commercialise new and better drugs for the treatment of cancer.
As a business, Santaris is committed to improving clinical outcomes for cancer patients, building a rapidly growing and successful business, and delivering realisable value to shareholders.